At the start of the new week, the stock barometers fell sharply. The fear of further restrictions in the Corona crisis, the profit warning from SAP and the decline in the ifo index gave the bears a tailwind today. Additional downward momentum arose after the US markets started and after a moderate start to trading also began to decline. The DAX® closed around 3.6 percent or 460 points in the red at 12,180 points. After a daily loss of 2.7 percent, the EuroStoxx®50 hit the September low of 3,110 points.
The turbulence in the stock markets weighed on bond yields today. The yield on 10-year Bunds fell to -0.575 percent and the yield on comparable US securities fell by four points to 0.80 percent. The precious metals also fell. It is true that the price of gold still defended the US $ 1,900 mark. Silver, on the other hand, fell below $ 24.50 and platinum closed around 3.5 percent lighter at $ 870. The oil price painted a similar picture. The price of a barrel of Brent crude oil plunged below $ 41.
Company in focus
AstraZeneca will continue the corona vaccine study again. The investors acknowledged the announcement with gains. Bayer takes over gene therapy specialist Asklepios Biopharmaceutical for four billion US dollars. The plans were well received by investors. Against the trend, the paper improved by almost one percent and thus continued to bottom out at around EUR 42. The German Lufthansa has reduced the winter flight schedule and is planning further cost-cutting measures. The share then fell over four percent. Hella wants to reduce dependency on the automotive sector and is therefore looking for takeover targets outside the area. Nevertheless, the MDAX® share continued the downward trend today. The share of SAP after a corona-related revision of the goals today, fell over 20 percent. The software company is sticking to the plans for the IPO of Qualtrics.
From Europe report next week among other things BP, Covestro, Novartis and Rational Business figures for the past quarter. In the US stand among other things AMD, Caterpillar, Eli Lilly, Microsoft and Pfizer with their business figures in focus.
- France – labor market data
- United States – Durable Goods Orders
- USA – Consumer Confidence
Chart technical outlook
Resistance marks: 12,420 / 12,670 points
Support marks: 11,985 / 12,220 points
The DAX® started with a downward gap today and then fell further to 12,200 points after stabilizing at noon. The index initially caught up in the area of the August low. A recovery to 12,350 points could trigger a short-term countermovement. However, many bulls will wait for a breakout above 12,420 points before entering. Until then, there is a risk that the downtrend will continue to 11,985 points.
DAX® in points; 4-hour chart (1 candle = 4 hours)
Observation period: July 22nd, 2020 – October 26th, 2020. Historical considerations are not reliable indicators for future developments. Source: tradingdesk.onemarkets.de
DAX® in points; Weekly chart (1 candle = 1 week)
Observation period: October 24, 2013 – October 23, 2020. Historical considerations are not reliable indicators for future developments. Source: tradingdesk.onemarkets.de
Inline warrants on the DAX®
|Underlying||WKN||Sales price in euros||Lower knock-out barrier in Pt.||Upper knock-out barrier in pt.||Final Valuation day|
|DAX®||HR03N7||2.70||12,000||15,100||December 17, 2020|
Source: HypoVereinsbank onemarkets; Status: 10/26/2020; 5:29 pm
You can find information about how inline warrants and numerous other products work here at onemarkets knowledge. You will find leverage and investment products for speculating on an upward or downward movement or sideways movement of the DAX® here.
NEW: Cashback trading – when the issuer pays my order fees!
Please note the important information and the disclaimer.
This information does not constitute investment advice, but advertising. The public offer is made exclusively on the basis of a securities prospectus approved by the Federal Financial Supervisory Authority (“BaFin”). Approval of the prospectus is not to be understood as a recommendation to purchase these UniCredit Bank AG securities. Only the prospectus including any supplements is relevant and the Final Terms. It is recommended that you read these documents carefully before making any investment decision in order to fully understand the potential risks and rewards of investing. You are about to acquire a product that is not easy and can be difficult to understand.
How the HVB products work